Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04793399
Title	Safety and Efficacy Evaluation of Bosutinib Plus Atezolizumab in Newly Diagnosed Chronic Leukemia Adult Patients
Recruitment	Terminated
Gender	both
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	Fundacion Espanola para la Curacion de la Leucemia Mieloide Cronica
Indications	chronic myeloid leukemia
Therapies	Atezolizumab + Bosutinib
Age Groups:	senior \| adult
Covered Countries	ESP